Package 31722-780-33

{"route": ["ORAL"], "spl_id": "44065ee4-1b6c-f3ef-e063-6394a90a797a", "openfda": {"nui": ["N0000175605", "N0000020009", "N0000187062", "N0000182137", "N0000187064", "N0000187063", "N0000191272", "N0000185503"], "unii": ["F41401512X"], "rxcui": ["746606", "997653"], "spl_set_id": ["86dc5507-ae0a-43d2-8d5e-5b0568ce9c5e"], "pharm_class_epc": ["Kinase Inhibitor [EPC]"], "pharm_class_moa": ["Bcr-Abl Tyrosine Kinase Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "UGT1A1 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "4 BLISTER PACK in 1 CARTON (31722-780-33)  / 28 CAPSULE in 1 BLISTER PACK", "package_ndc": "31722-780-33", "marketing_start_date": "20251119"}], "brand_name": "Nilotinib", "product_id": "31722-780_44065ee4-1b6c-f3ef-e063-6394a90a797a", "dosage_form": "CAPSULE", "pharm_class": ["Bcr-Abl Tyrosine Kinase Inhibitors [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Kinase Inhibitor [EPC]", "P-Glycoprotein Inhibitors [MoA]", "UGT1A1 Inhibitors [MoA]"], "product_ndc": "31722-780", "generic_name": "Nilotinib", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Nilotinib", "active_ingredients": [{"name": "NILOTINIB", "strength": "200 mg/1"}], "application_number": "ANDA209651", "marketing_category": "ANDA", "marketing_start_date": "20251119", "listing_expiration_date": "20261231"}